| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income | 34,794 | 35,709 | 39,268 | 62,802 |
| Net loss | -509,940 | -688,703 | -903,141 | -436,671 |
| Basic net loss per share | -0.33 | -0.45 | -0.59 | -0.28 |
| Diluted net loss per share | -0.33 | -0.45 | -0.59 | -0.28 |
| Weighted-average shares of common stock outstanding, basic | 1,542,139 | 1,542,139 | 1,542,139 | 1,541,722 |
| Weighted-average shares of common stock outstanding, diluted | 1,542,139 | 1,542,139 | 1,542,139 | 1,541,722 |
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)